Ask The Recruiter

Climb Bio, Inc.

Leadership moves, last update 2 months ago

Pharma biotech · Headquarters United States

Everything we hold on Climb Bio, Inc., newest first. Every line links to the filing or report it came from.

3 updates tracked
$110M disclosed funding
2 leadership changes
3 Apr 2026 tracked since
United States where
  1. 2026-07-01
    Headcount Not Stated Leadership moves

    Climb Bio, Inc. Announces Leadership Changes

    Climb Bio, Inc. sees a change in its board leadership with the resignation of Andrew Levin and the election of Breanna O’Reilly.

    United States · Official Filing · SEC EDGAR

  2. 2026-05-04
    Headcount Not Stated Growing and expanding

    Climb Bio, Inc. raised $110.1M in a private placement

    Climb Bio, Inc. reported a $110.1M private placement to the SEC on 2026-05-04, listing an address in MA. The filing records the money only; it names no roles and no hiring plan.

    United States · $110M raised · Official Filing · SEC EDGAR (Form D)

  3. 2026-04-03
    Headcount Not Stated Leadership moves

    Climb Bio, Inc. 8-K filing: officer or director change

    Climb Bio replaces its finance leadership in Wellesley Hills, with no announced impact beyond the executive team.

    United States · Official Filing · SEC EDGAR

Cite this pageClimb Bio, Inc.. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/climb-bio/ Licensed CC BY 4.0; every record links to the document behind it.

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker